v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net sales $ 123,568 $ 115,800
Cost of sales (85,151) (85,609)
Gross profit 38,417 30,191
Operating expenses    
Selling, general and administrative (27,713) (26,628)
Research, product development and regulatory (5,271) (5,682)
Product liability claims (81) 0
Transformation (2,804) (2,191)
Asset impairments (659) 0
Operating income (loss) 1,889 (4,310)
Change in fair value of an equity investment (120) 0
Interest expense, net (5,790) (3,765)
Loss before provision for income taxes (4,021) (8,075)
Income tax expense (124) (387)
Net loss $ (4,145) $ (8,462)
Net loss per common share-basic $ (0.14) $ (0.3)
Net loss per common share-assuming dilution $ (0.14) $ (0.3)
Weighted average shares outstanding—basic 28,649 28,271
Weighted average shares outstanding—assuming dilution 28,649 28,271